In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction.
In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction.